Related Experiment Video
Updated: May 4, 2026
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
2.2K
[Biomarkers in heart failure: an update].
Giornale Italiano Di Cardiologia (2006)
|December 17, 2013
Summary
Heart failure (HF) prognosis is poor, necessitating advanced diagnostic and therapeutic strategies. Biomarkers, like B-type natriuretic peptides, show promise for personalized HF management and improved patient outcomes.
Area of Science:
- Cardiology
- Biomarker Research
- Pathophysiology
Context:
- Heart failure (HF) is a major cardiovascular disease outcome with a poor prognosis.
- Current diagnostic and therapeutic approaches require enhancement for complex HF syndromes.
- Hemodynamic alterations, structural changes, and adrenergic activation characterize HF pathophysiology.
Purpose:
- To explore novel decision-making strategies for HF management.
- To highlight the role of biomarkers in early diagnosis, risk stratification, and treatment definition for HF.
- To discuss the potential of biomarker tracking for managing heterogeneous HF phenotypes.
Summary:
- Biomarkers, particularly B-type natriuretic peptides, are increasingly recognized for their diagnostic and prognostic value in HF.
- Advanced strategies incorporating biomarker tracking are needed to address the complex pathophysiology of HF.
- Personalized management based on specific pathophysiologic pathways is a future direction for HF treatment.
Impact:
- Improved early diagnosis and risk stratification of heart failure patients.
- Enhanced personalized treatment strategies for diverse HF clinical presentations.
- Potential for better patient follow-up and management through biomarker monitoring.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
01:26Heart Failure III: Clinical Manifestations
1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
01:17Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
1.0K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
01:27Heart Failure I: Introduction
1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K